Atlas Trials

Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus

Clinical trial NCT00195468 · COMPLETED

Trial details

NCT number
NCT00195468
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Kidney FailureGraft vs Host Disease
Start date
2004-03-01
Primary completion
2006-11-01
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.